Role of Steroids in Community-Acquired Pneumonia
Steroids should not be routinely used in community-acquired pneumonia (CAP) but may benefit specific patient subgroups with severe CAP, particularly those with septic shock refractory to fluid resuscitation and with elevated CRP >150 mg/L. 1, 2
General Recommendation
The 2019 IDSA/ATS guidelines provide a strong conditional recommendation against the routine use of adjunctive steroids in patients treated for CAP 1. This position is supported by multiple studies showing:
- No significant mortality reduction in general CAP populations 1, 3, 4
- Potential for adverse effects including hyperglycemia (RR 1.49; 95% CI 1.01−2.19) 2
- Increased risk of late failure (>72h after admission) with prednisolone (19.2% vs 6.4%, P = 0.04) 3
Specific Scenarios Where Steroids May Be Beneficial
Severe CAP with Septic Shock
- Consider steroids in severe CAP with septic shock refractory to fluid resuscitation and vasopressor use 1
- Particularly beneficial when CRP >150 mg/L 1
- Meta-analyses have shown significant mortality reduction in severe CAP subgroups (OR = 0.26,95% CI: 0.11–0.64) 1, 5
- Recent data suggests patients with high CRP (>204 mg/L) may derive greater mortality benefit (OR 0.43 [95% CI 0.25-0.76]) 6
Potential Benefits in Appropriate Patients
- Reduced time to clinical stability 1, 7
- Shortened hospital length of stay by approximately 1-3 days 1, 2, 7
- Decreased risk of ARDS (RR 0.21,95% CI 0.08-0.59) 2
- Reduced need for mechanical ventilation (RR 0.45,95% CI 0.26-0.79) 2
Contraindications and Cautions
- Avoid in viral pneumonia, especially influenza, as meta-analyses show increased mortality 1, 2
- Not recommended for non-severe CAP not requiring oxygen supplementation 2
- Increased risk of hyperglycemia (OR 2.50 [95% CI 1.63-3.83]) 6
- Increased risk of hospital readmission (OR 1.95 [1.24-3.07]) 6
Recommended Regimens When Indicated
For severe CAP with septic shock and elevated CRP:
- Methylprednisolone 0.5 mg/kg IV every 12 hours for 5 days 1, 2
- OR Prednisone 50 mg daily for 5 days (for patients who can take oral medication) 1
- OR Hydrocortisone <400 mg/day IV for 5-7 days 2
Monitoring During Steroid Treatment
- Close glucose monitoring, especially in first 36 hours after initiation 2
- Implement infection surveillance as steroids blunt febrile response 2
- Evaluate response at 72 hours 2
- Consider GI prophylaxis with proton pump inhibitors 2
Algorithm for Decision-Making
- Assess CAP severity using validated tools (PSI or CURB-65)
- Check if patient has:
- Severe CAP requiring ICU admission
- Septic shock refractory to fluid resuscitation and vasopressors
- CRP >150 mg/L
- Rule out viral pneumonia, especially influenza
- If criteria in step 2 are met and step 3 is negative, consider steroid therapy
- Use recommended dosing regimen and monitor for adverse effects
- Discontinue if no improvement after 72 hours or if complications develop